Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors.
Science. 2019 Nov 8;366(6466):714-723. doi: 10.1126/science.aaw9032.
Science. 2019.
PMID: 31699932
Free PMC article.